Nas Diagnostics & Pathlabs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -28.02%
(FY 2022)
- Ebitda -28.02%
(FY 2022)
- Net Worth
- Total Assets 18.06%
(FY 2022)
About Nas Diagnostics & Pathlabs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Malik and Bhavna Tiwari serve as directors at the Company.
- CIN/LLPIN
U74120UP2015PTC073845
- Company No.
073845
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nas Diagnostics & Pathlabs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Malik  | Director | 14-Oct-2015 | Current |
| Bhavna Tiwari | Director | 14-Oct-2015 | Current |
Financial Performance of Nas Diagnostics & Pathlabs.
Nas Diagnostics & Pathlabs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 28.02% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nas Diagnostics & Pathlabs?
In 2019, Nas Diagnostics & Pathlabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sapro Electronics & Electricals (India) Private LimitedActive 14 years 7 monthsNitin Malik is a mutual person
- Saranya Health Services Private LimitedActive 9 years 6 months
Nitin Malik and Bhavna Tiwari are mutual person
- Nasvista Pharmacy Private LimitedActive 9 years 2 months
Nitin Malik and Bhavna Tiwari are mutual person
- Caventus Healthcare Private LimitedActive 6 years 8 months
Nitin Malik and Bhavna Tiwari are mutual person
- Apus Nova Healthcare Private LimitedActive 3 years 5 months
Nitin Malik and Bhavna Tiwari are mutual person
- Saranya Kotdwar Private LimitedActive 2 years 11 months
Nitin Malik and Bhavna Tiwari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nas Diagnostics & Pathlabs?
Unlock and access historical data on people associated with Nas Diagnostics & Pathlabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nas Diagnostics & Pathlabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nas Diagnostics & Pathlabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
